GF
VRTX icon

Gabelli Funds’s Vertex Pharmaceuticals VRTX Stock Holding History

Gabelli Funds’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.54M Sell
7,920
-64
-0.8% -$29.8K 0.02% 591
2025
Q4 		$3.62M Sell
7,984
-7,018
-47% -$3.02M 0.02% 577
2025
Q3 		$5.88M Sell
15,002
-1,327
-8% -$555K 0.04% 450
2025
Q2 		$7.27M Sell
16,329
-21
-0.1% -$9.68K 0.05% 389
2025
Q1 		$7.93M Sell
16,350
-1,324
-7% -$617K 0.06% 343
2024
Q4 		$7.12M Buy
17,674
+275
+2% +$127K 0.05% 362
2024
Q3 		$8.09M Sell
17,399
-4,693
-21% -$2.25M 0.06% 345
2024
Q2 		$10.4M Sell
22,092
-217
-1% -$94.2K 0.08% 303
2024
Q1 		$9.33M Sell
22,309
-480
-2% -$203K 0.07% 321
2023
Q4 		$9.27M Buy
22,789
+105
+0.5% +$38.8K 0.07% 310
2023
Q3 		$7.89M Sell
22,684
-465
-2% -$163K 0.06% 340
2023
Q2 		$8.15M Sell
23,149
-1,492
-6% -$503K 0.06% 346
2023
Q1 		$7.76M Buy
24,641
+1,477
+6% +$443K 0.06% 364
2022
Q4 		$6.69M Buy
23,164
+1,158
+5% +$353K 0.05% 391
2022
Q3 		$6.37M Sell
22,006
-4,095
-16% -$1.18M 0.05% 396
2022
Q2 		$7.36M Sell
26,101
-11,861
-31% -$3.17M 0.06% 383
2022
Q1 		$9.91M Buy
37,962
+6,666
+21% +$1.58M 0.07% 347
2021
Q4 		$6.87M Buy
31,296
+6,000
+24% +$1.17M 0.04% 433
2021
Q3 		$4.59M Buy
25,296
+15,421
+156% +$3.01M 0.03% 528
2021
Q2 		$1.99M Buy
+9,875
New +$2.07M 0.01% 755

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Gabelli Funds's VRTX Position: Q1 2026 in Review

Gabelli Funds reduced its Vertex Pharmaceuticals (VRTX) stake by 0.8% in Q1 2026, selling an estimated $29.8K and leaving 7,920 shares worth $3.54M. The position accounts for 0.02% of the portfolio, ranked #591.

Gabelli Funds first reported a position in VRTX in Q2 2021 and has held it in 20 quarters since. The position peaked at $10.4M in Q2 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Gabelli Funds held 7,920 shares of Vertex Pharmaceuticals worth $3.54M as of Q1 2026.
  • Gabelli Funds sold 64 Vertex Pharmaceuticals shares in Q1 2026, an estimated $29.8K.
  • Vertex Pharmaceuticals made up 0.02% of Gabelli Funds's portfolio in Q1 2026, its #591 holding.
  • Gabelli Funds first reported a position in Vertex Pharmaceuticals in Q2 2021 and has held it in 20 quarters since.
  • Gabelli Funds's Vertex Pharmaceuticals position peaked at $10.4M in Q2 2024.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Gabelli Funds's 13F filing for Q1 2026, filed 14 May 2026.